USC News

Menu Tuesday, April 23, 2019

Health Care

Search
Health
CAR T-cell therapy
This colored scanning electron micrograph shows a T cell (red) attached to a cancer cell. CAR T-cell therapy involves harvesting T-cells from a patient, reengineering them in the lab to target a particular kind of cancer, then reinfusing them into the patient. (Image/Steve Gschmeissner, Science Source)

USC-led advance in groundbreaking cancer treatment eliminates severe side effects

Though the study was designed to assess safety, six out of 11 lymphoma patients who received a commonly used dose of the improved CAR T-cell therapy went into complete remission.

HealthUniversity
USC hospitals anniversary
The USC Trojan Marching Band performs in front of USC University Hospital during a celebration marking USC’s purchase of the hospital and USC Norris Cancer Hospital in 2009. (Photo/Veronica Jauriqui)

Keck Medicine of USC celebrates 10-year anniversary of hospitals purchase

Hailed as a “tremendous victory,” the acquisition of Keck Hospital of USC and USC Norris Cancer Hospital created the second full-service academic medical center of its kind in the greater Los Angeles region.

Health
Young Scientists Program JEP
Martin Kast of the Keck School of Medicine of USC explains an experiment to two elementary school students in a cancer education workshop organized by the Joint Educational Project’s Young Scientists Program, as graduate student Ruben Prins looks on. (USC Photo/Susan Bell)

Children hear from people on the front lines of cancer research, prevention and treatment

USC Dornsife’s Young Scientist Program hosts workshops at L.A. elementary schools to reduce the fear of cancer and encourage the pursuit of science.

HealthScience/Technology
postpartum bleeding drug activation
Some important conditions are treated by misoprostol, including ulcers, bleeding inflammation, pain and labor. Illustrated here is misoprostol in the binding site of the hormone prostaglandin E2 receptor 3. (Illustration/Yekaterina Kadyshevskaya)

Better drug to save mothers’ lives during childbirth may be on the way

Scientists at the USC Michelson Center for Convergent Bioscience and Stanford University take first step toward a safer drug for reducing postpartum bleeding.